Centrum Onkologii i Hipertermii

Warsaw 02-781

0 studies enrolling now · 2 studies all time

What they study most

Indolent Non-Hodgkin's Lymphomas

Studies at this site

• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early